Aclaris Therapeutics, Inc. Annual Cost of Revenue in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from 2017 to 2023.
  • Aclaris Therapeutics, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $654K, a 22.9% decline year-over-year.
  • Aclaris Therapeutics, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $2.81M, a 21.3% decline year-over-year.
  • Aclaris Therapeutics, Inc. annual Cost of Revenue for 2023 was $3.42M, a 14.9% decline from 2022.
  • Aclaris Therapeutics, Inc. annual Cost of Revenue for 2022 was $4.02M, a 14.6% decline from 2021.
  • Aclaris Therapeutics, Inc. annual Cost of Revenue for 2021 was $4.71M, a 8.18% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.42M -$600K -14.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $4.02M -$690K -14.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $4.71M -$420K -8.18% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $5.13M +$1.08M +26.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $4.06M -$274K -6.33% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $4.33M +$3.12M +259% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $1.21M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.